BNP Paribas Financial Markets’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.8K Sell
5,754
-2,714
-32% -$12K ﹤0.01% 5200
2026
Q1
$30.6K Sell
8,468
-79,816
-90% -$276K ﹤0.01% 4937
2025
Q4
$301K Buy
88,284
+73,381
+492% +$356K ﹤0.01% 3859
2025
Q3
$101K Sell
14,903
-201,995
-93% -$1.67M ﹤0.01% 4292
2025
Q2
$2.95M Buy
216,898
+168,871
+352% +$1.59M ﹤0.01% 2202
2025
Q1
$261K Sell
48,027
-8,304
-15% -$47.1K ﹤0.01% 3563
2024
Q4
$279K Buy
+56,331
New +$295K ﹤0.01% 3680

Other funds holding LFMD

BNP Paribas Financial Markets's LFMD Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its LifeMD (LFMD) stake by 32% in Q2 2026, selling an estimated $12K and leaving 5,754 shares worth $23.8K. The position accounts for ﹤0.01% of the portfolio, ranked #5200.

BNP Paribas Financial Markets first reported a position in LFMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.95M in Q2 2025. 108 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • BNP Paribas Financial Markets held 5,754 shares of LifeMD worth $23.8K as of Q2 2026.
  • BNP Paribas Financial Markets sold 2,714 LifeMD shares in Q2 2026, an estimated $12K.
  • LifeMD made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5200 holding.
  • BNP Paribas Financial Markets first reported a position in LifeMD in Q4 2024 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's LifeMD position peaked at $2.95M in Q2 2025.
  • 108 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.